Form 8-K - Current report:
SEC Accession No. 0001104659-24-117243
Filing Date
2024-11-13
Accepted
2024-11-13 07:37:33
Documents
15
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428074d1_8k.htm   iXBRL 8-K 26054
2 EXHIBIT 99.1 tm2428074d1_ex99-1.htm EX-99.1 61753
6 GRAPHIC tm2428074d1_ex99-1img001.jpg GRAPHIC 13018
  Complete submission text file 0001104659-24-117243.txt   289068

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20241113.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20241113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20241113_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428074d1_8k_htm.xml XML 3699
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 241451202
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)